The Court of Appeal has dismissed an appeal by Gilead Sciences aiming to halt two companies who produce and supply generic HIV drugs from putting any product containing a combination of two particular anti-retroviral agents on the Irish market.
On Tuesday, February 2, the Court of Appeal upheld a High Court decision revoking Gilead’s supplemental […] The post Gilead loses appeal to prevent generic HIV drug entering Irish market appeared first on GCN.